Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy? : Achieving Curent Goals in Prevention and Treatment of Vascular Disease: An UpdateMILIONIS, Haralampos; MICHEL, Patrik.Current pharmaceutical design (Print). 2013, Vol 19, Num 21, pp 3788-3794, issn 1381-6128, 7 p.Article

Anderson-Fabry Disease: A Multiorgan Disease : Anderson Fabry Disease: A Multiorgan Metabolic Disease Susceptible of TreatmentTUTTOLOMONDO, Antonino; PECORARO, Rosaria; SIMONETTA, Irene et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5974-5996, issn 1381-6128, 23 p.Article

Antimalarial Drug Resistance and Early Drug Discovery : Antimalarial Drug Discovery and Design in the Era of ResistanceGARCIA-BUSTOS, Jose F; GAMO, Francisco-Javier.Current pharmaceutical design (Print). 2013, Vol 19, Num 2, pp 270-281, issn 1381-6128, 12 p.Article

CFTR Inhibitors : Cystic Fibrosis: CFTR Modulators and their Mechanism of ActionVERKMAN, Alan S; SYNDER, David; TRADTRANTIP, Lukmanee et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 19, pp 3529-3541, issn 1381-6128, 13 p.Article

Corticosteroids for the Inflammatory Response to Cardiopulmonary Bypass: An Update : Current Situation at Perioperative of Cardiovascular Disease Patients: New Addressing and Perioperative Optimization TechniquesDIELEMAN, Jan M.Current pharmaceutical design (Print). 2013, Vol 19, Num 22, pp 3979-3991, issn 1381-6128, 13 p.Article

Dendritic Cells in Atherosclerosis : Novel Targets and Biomarkers for Anti-atherosclerotic TherapyCARTLAND, Siân P; JESSUP, Wendy.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5883-5890, issn 1381-6128, 8 p.Article

Deubiquitinating Enzymes as Promising Drug Targets for Infectious Diseases : Targeting the Ubiquitin-Proteasome Pathway - Current Perspectives and Future DirectionsNANDURI, Bindu; SUVARNAPUNYA, Akamol E; VENKATESAN, Malabi et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 18, pp 3234-3247, issn 1381-6128, 14 p.Article

Device-based Therapies for Resistant Hypertension : Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular DamageBRUNO, Rosa Maria; DI GIULIO, Alessia; BERNINI, Giampaolo et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 13, pp 2401-2408, issn 1381-6128, 8 p.Article

Diagnostic Tests for the Detection of Human Papillomavirus-associated Cervical Lesions : Explorating Molecular and Clinical Management of Patients int he Follow up of the HPV Related Uterine LesionsREUSCHENBACH, Miriam; VON KNEBEL DOEBERITZ, Magnus.Current pharmaceutical design (Print). 2013, Vol 19, Num 8, pp 1358-1370, issn 1381-6128, 13 p.Article

Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention : Novel Targets and Biomarkers for Anti-atherosclerotic TherapyOREKHOV, Alexander N.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5909-5928, issn 1381-6128, 20 p.Article

Discovery of Small Molecule Fusion Inhibitors Targeting HIV-1 gp41 : The Development of Novel Inhibitors for the Treatment of HIV InfectionGUANGYAN ZHOU; SHIDONG CHU.Current pharmaceutical design (Print). 2013, Vol 19, Num 10, pp 1818-1826, issn 1381-6128, 9 p.Article

Effect of Aging on Metabolic Pathways in Endothelial Progenitor Cells : Modifying Cardiovascular Risk Factors: New Markers of Cardiovascular DamageFELICE, Francesca; BARSOTTI, Maria Chiara; POREDOS, Pavel et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 13, pp 2351-2365, issn 1381-6128, 15 p.Article

Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN : Molecular Modeling and QSAR Studies for Drug DesignDEEB, Omar; JAWABREH, Sana; GOODARZI, Mohammad et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 12, pp 2237-2244, issn 1381-6128, 8 p.Article

F508del-CFTR Rescue: A Matter of Cell Stress Response : Cystic Fibrosis: CFTR Modulators and their Mechanism of ActionNIEDDU, Erika; POLLAROLO, Benedetta; MERELLO, Luisa et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 19, pp 3476-3496, issn 1381-6128, 21 p.Article

Gene Delivery Strategies Targeting Stable Atheromatous Plaque : Stable Angina Pectoris: Novel Therapeutics InsightsVAN-ASSCHE, Tim; HUYGELEN, Veronique; CRABTREE, Mark J et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 9, pp 1626-1637, issn 1381-6128, 12 p.Article

Gene Therapy for Bone Regeneration : Bone Morphogenetics Proteins for Bone Regeneration and Their AlternativesPENSAK, Michael J; LIEBERMAN, Jay R.Current pharmaceutical design (Print). 2013, Vol 19, Num 19, pp 3466-3473, issn 1381-6128, 8 p.Article

Good, Bad, Mobile Elements: Genome's Most Successful Parasites as Emerging Players in Cell and Organismal Aging : Cellular Senescence and Inflammation: Advances and Therapeutic Targets in Aging and Major Age-Related DiseasesCARDELLI, Maurizio; MARCHEGIANI, Francesca.Current pharmaceutical design (Print). 2013, Vol 19, Num 9, pp 1739-1752, issn 1381-6128, 14 p.Article

Hsp70 Protein Complexes as Drug Targets : Molecular Chaperones as Drug TargetsASSIMON, Victoria A; GILLIES, Anne T; RAUCH, Jennifer N et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 404-417, issn 1381-6128, 14 p.Article

Immune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised : Cellular Senescence and Inflammation: Advances and Therapeutic Targets in Aging and Major Age-Related DiseasesSALVIOLI, Stefano; MONTI, Daniela; BUCCI, Laura et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 9, pp 1675-1679, issn 1381-6128, 5 p.Article

Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis : Novel Targets and Biomarkers for Anti-atherosclerotic TherapyROSAS, Elisabet; SOBENIN, Igor; OREKHOV, Alexander et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 33, pp 5897-5903, issn 1381-6128, 7 p.Article

Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins : New Insights into Insulin Resistance, Cardiovascular Diseases and Oxidative Stress: Pathophysiological and Clinical ConsequencesBAGUL, Pankaj K; BANERJEE, Sanjay K.Current pharmaceutical design (Print). 2013, Vol 19, Num 32, pp 5663-5677, issn 1381-6128, 15 p.Article

Macromolecular Structure Comparison and Docking: An Algorithmic Review : Molecular Modeling and QSAR Studies for Drug DesignPAQUET, Eric; VIKTOR, Herna L.Current pharmaceutical design (Print). 2013, Vol 19, Num 12, pp 2183-2193, issn 1381-6128, 11 p.Article

Mechanisms, Prevention and Treatment of Distal Embolization : No Reflow: What's in a Name?PORTO, Italo; LUIGI DE MARIA, Giovanni; PIERONI, Maurizio et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 25, pp 4576-4585, issn 1381-6128, 10 p.Article

Mesenchymal Stem/Stromal Cells: A New Cells as Drugs Paradigm. Efficacy and Critical Aspects in Cell TherapyDE GIROLAMO, Laura; LUCARELLI, Enrico; LOCATELLI, Franco et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 13, pp 2459-2473, issn 1381-6128, 15 p.Article

MicroRNA Dysregulation in Gastric Cancer : miRNA in the Pathogenesis and Therapy for Gastrointestinal and Hepatic CancersPAN, Hung-Wei; LI, Sung-Chou; TSAI, Kuo-Wang et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 7, pp 1273-1284, issn 1381-6128, 12 p.Article